TRxADE HEALTH, Inc. Common Stock

TRxADE Health, Inc. is changing its name to Scienture Holdings, Inc. and its stock will trade under the new ticker symbol SCNX. Scienture, LLC, a wholly-owned subsidiary, is a branded specialty pharmaceutical company that recently merged with TRxADE Health.

Related tickers: MEDS.

TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

Related tickers: MEDS.